Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Altimmune to Announce Year End 2017 Financial Results on March 29

Posted on: 20 Mar 18

GAITHERSBURG, Md., March 20, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced that it will announce financial results for the quarter and year ended December 31, 2017 before the market open and host a conference call on Thursday, March 29.

Conference Call Details   
Date:  Thursday, March 29
Time:  8:30am Eastern Time
Domestic:  866-548-4713
International:  323-794-2093
Conference ID:  6280732
Replays, Available through April 12th:
Domestic:  844-512-2921
International:  412-317-6671
Replay PIN:   6280732

About Altimmune
Altimmune is a clinical-stage immunotherapeutics company focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of disease including NasoVAX, a Phase 2 seasonal influenza vaccine candidate, and HepTcell, a Phase 1 immunotherapeutic candidate for the potential cure of chronic hepatitis B. The company also has two United States government funded, next-generation anthrax vaccine candidates that are intended to improve protection and safety while having favorable dosage and storage requirements compared to other anthrax vaccines.

Bill Enright                                                                                                          
President and CEO                                                                                         
Phone: 240-654-1450                                                                                                                                                          

Ashley Robinson
LifeSci Advisors, LLC


Last updated on: 21/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.